Cargando…
Gene expression profiles of inflammatory breast cancer reveal high heterogeneity across the epithelial-hybrid-mesenchymal spectrum
Inflammatory breast cancer (IBC) is a highly aggressive breast cancer that metastasizes largely via tumor emboli, and has a 5-year survival rate of less than 30%. No unique genomic signature has yet been identified for IBC nor has any specific molecular therapeutic been developed to manage the disea...
Autores principales: | Chakraborty, Priyanka, George, Jason T, Woodward, Wendy A, Levine, Herbert, Jolly, Mohit Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851345/ https://www.ncbi.nlm.nih.gov/pubmed/33535154 http://dx.doi.org/10.1016/j.tranon.2021.101026 |
Ejemplares similares
-
Comparative Study of Transcriptomics-Based Scoring Metrics for the Epithelial-Hybrid-Mesenchymal Spectrum
por: Chakraborty, Priyanka, et al.
Publicado: (2020) -
Transcriptomic-Based Quantification of the Epithelial-Hybrid-Mesenchymal Spectrum across Biological Contexts
por: Mandal, Susmita, et al.
Publicado: (2021) -
A mechanism for epithelial-mesenchymal heterogeneity in a population of cancer cells
por: Tripathi, Shubham, et al.
Publicado: (2020) -
Quantifying the Patterns of Metabolic Plasticity and Heterogeneity along the Epithelial–Hybrid–Mesenchymal Spectrum in Cancer
por: Muralidharan, Srinath, et al.
Publicado: (2022) -
Analysis of immune subtypes across the epithelial-mesenchymal plasticity spectrum
por: Chakraborty, Priyanka, et al.
Publicado: (2021)